MedPath

A study to assess the effect Of the drug Tranexamic acid in reducing bloos loss during early excision of burn wound.

Phase 4
Conditions
Health Condition 1: null- Those Who Sustained Less Than 40% Burns And Hemodynamically Stable
Registration Number
CTRI/2017/09/009629
Lead Sponsor
Dept Of Plastic Surgery
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients presenting with thermal burns involving upto 30% TBSA with deep thermal component of atleast 5 % TBSA.

2.The thermal injury should be less than or equal to 6 days old

3.Age between 15-50 years

Exclusion Criteria

1.Inhalational injury

2.Chemical & electrical burns

3.Burn injury >6 days old

4.Associated major injuries (head,chest,abdominal trauma)

5.Patient with history of bleeding disorders and on anticoagulation treatment

6.Non consenting patients

7.H/o Deep Vein Thrombosis,Myocardial infarction,CerebroVascular accident

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To find the difference in average blood loss per cm2 area excised in patients who are given intravenous tranexamic acid during early tangential excision grafting of the burn wounds versus a control group <br/ ><br>To find the average amount of blood transfusion requirement per cm2 area excised and average fluid requirements during the intra operative period <br/ ><br>Timepoint: at the time of primary dressing,ie on post operative day 5 <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
TO Find the average blood transfusion required per cm2 during tangential excision. <br/ ><br>Percentage of graft takeTimepoint: On post operative day 5
© Copyright 2025. All Rights Reserved by MedPath